To include your compound in the COVID-19 Resource Center, submit it here.

CHMP recommends against Santhera's Raxone for DMD

EMA's CHMP recommended against approving an MAA for Raxone idebenone (SNT-MC17) from Santhera

Read the full 137 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE